SAN DIEGO, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Cue Health Inc. (Cue) announced today that, as of November 9, the U.S. Department of Health and Human Services (HHS) began deploying its molecular, ...
Cue Health developed a rapid COVID-19 test that's become the new gold standard: fast, reliable, and easy to use. The company is now getting ready to IPO.
SAN DIEGO--(BUSINESS WIRE)--Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced that it has been awarded a new approximately $28 million contract by the Biomedical Advanced ...
Cue Health (HLTH) made a name for itself with a rapid at-home COVID-19 test, a machine with a $200 price tag, and is out with 13 new tests this week, though none is compatible with the new machine.
SAN DIEGO--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced it has received Emergency Use Authorization (EUA) from the United States Food and Drug ...
San Diego-based Cue Health, a developer of rapid molecular testing products, has raised $100M in a Series C funding round, the company said this week. The funding came from Decheng Capital, Foresite ...
Cue Health, a San Diego biotech that ascended during the pandemic through mega funding and partnerships for its rapid COVID-19 test, said Wednesday that it is laying off half of its workforce as it ...
Cue Health, a San Diego-based medical tech company, announced Wednesday that it’s laying off about half of its already-sharply shrunken workforce. Cue spokesperson Jessie Wick told SFGATE in an email ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback